CA2024694A1 - Acyloxymethyl esters de l'acide bisphosphonique utilises comme inhibiteurs de la resorption osseuse - Google Patents

Acyloxymethyl esters de l'acide bisphosphonique utilises comme inhibiteurs de la resorption osseuse

Info

Publication number
CA2024694A1
CA2024694A1 CA2024694A CA2024694A CA2024694A1 CA 2024694 A1 CA2024694 A1 CA 2024694A1 CA 2024694 A CA2024694 A CA 2024694A CA 2024694 A CA2024694 A CA 2024694A CA 2024694 A1 CA2024694 A1 CA 2024694A1
Authority
CA
Canada
Prior art keywords
bisphosphonic acids
bone resorption
acyloxymethyl esters
resorption inhibitors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2024694A
Other languages
English (en)
Other versions
CA2024694C (fr
Inventor
Walfred S. Saari
Paul S. Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CA2024694A1 publication Critical patent/CA2024694A1/fr
Application granted granted Critical
Publication of CA2024694C publication Critical patent/CA2024694C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002024694A 1989-09-06 1990-09-05 Acyloxymethyl esters de l'acide bisphosphonique utilises comme inhibiteurs de la resorption osseuse Expired - Fee Related CA2024694C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40341189A 1989-09-06 1989-09-06
US403,411 1989-09-06

Publications (2)

Publication Number Publication Date
CA2024694A1 true CA2024694A1 (fr) 1991-03-07
CA2024694C CA2024694C (fr) 2000-10-17

Family

ID=23595658

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002024694A Expired - Fee Related CA2024694C (fr) 1989-09-06 1990-09-05 Acyloxymethyl esters de l'acide bisphosphonique utilises comme inhibiteurs de la resorption osseuse

Country Status (5)

Country Link
EP (1) EP0416689B1 (fr)
JP (1) JPH07119230B2 (fr)
CA (1) CA2024694C (fr)
DE (1) DE69023844T2 (fr)
LV (1) LV11473B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0594857B1 (fr) * 1991-09-05 1998-04-29 Toray Industries, Inc. Derive d'acide methanediphosphonique, sa production et son utilisation comme remede
US5283057A (en) * 1992-04-24 1994-02-01 The Procter & Gamble Company Risedronate in oral compositions
WO1993024496A1 (fr) * 1992-05-29 1993-12-09 Procter & Gamble Pharmaceuticals, Inc. Composes de phosphonate contenant du soufre, et destines au traitement du metabolisme anormal du calcium et du phosphate
TW398975B (en) 1994-07-22 2000-07-21 Lilly Co Eli Pharmaceutical composition for inhibiting bone loss
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
FI104901B (fi) * 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2451881A1 (fr) * 2001-07-16 2003-01-30 Universite Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
FR2837490B1 (fr) * 2002-03-21 2009-04-17 Univ Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
US6927036B2 (en) 2002-02-19 2005-08-09 Xero Port, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
US7662987B2 (en) 2003-07-15 2010-02-16 Xenoport, Inc. Methods for synthesis of acyloxyalkyl compounds
KR20110097942A (ko) 2003-08-20 2011-08-31 제노포트 인코포레이티드 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
ES2405329T3 (es) 2003-12-30 2013-05-30 Xenoport, Inc. Síntesis de profármacos de carbarnato de aciloxialquilo y productos intermedios de los mismos
US7351740B2 (en) 2005-06-20 2008-04-01 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
US7531572B2 (en) 2006-07-28 2009-05-12 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2745083C2 (de) * 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
GB8419489D0 (en) * 1984-07-31 1984-09-05 Leo Pharm Prod Ltd Chemical compounds
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
CA2024694C (fr) 2000-10-17
DE69023844D1 (de) 1996-01-11
LV11473B (en) 1996-12-20
EP0416689B1 (fr) 1995-11-29
LV11473A (lv) 1996-08-20
JPH07119230B2 (ja) 1995-12-20
EP0416689A2 (fr) 1991-03-13
DE69023844T2 (de) 1996-06-20
JPH03106893A (ja) 1991-05-07
EP0416689A3 (en) 1991-06-26

Similar Documents

Publication Publication Date Title
CA2149052A1 (fr) Formulations sous forme de melange sec pour acides bisphosphoniques
CA2188567A1 (fr) Composition pour acides bisphosphoniques a granulation par voie humide
PT1914237E (pt) Compostos antivíricos de éster fosfonato
PT939748E (pt) Placas de gesso que têm maior resistência à deformação permanente
CA2018477A1 (fr) Procede pour la preparation du 4-amino-1-hydroxybutylidene-1,1-biphosphonate acide de monosodium, trihydrate
PT968228E (pt) Complexos de cálcio e fosfopeptídeos
AU1876788A (en) Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
EP0416689A3 (en) Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
CA2035179A1 (fr) Composition pharmaceutique contenant des sels insolubles d'acides biphosphonique
EP0341961A3 (fr) Acides polymaloniques comme agents ayant une affinité osseuse
BR9808233A (pt) Preparação farmacêutica
HUP9802219A3 (en) Processes for the preparation of n-phosphonomethylglycine from n-phosphonomethyliminodiacetic acid
CA2271259A1 (fr) Supplement alimentaire
GB8902740D0 (en) Process for the preparation of triaryl phosphate
HU901602D0 (en) Continuous process for the production of solid calcium phosphates from raw phosphate without the addition of phosphoric acid and lime
LTIP1742A (en) Process for the preparation of phosphoric or thiophosphoric acid ethylenimides
EP0417558A3 (en) S-haloalkyl(di)(tri)(thio)phosphoric(phosphonic)acid(amide) esters
EP0723968A3 (fr) Procédé de préparation de 0,0'-diesters d'acide thiophosphorique et leurs sels ainsi que leur utilisation
HK1028612A (en) Diphosphonic acid salts for the treatment of osteoporosis
HUP0004653A3 (en) The use of bisphosphonates for producing medicaments use ful for inhibiting bone resorption
FR2620118B1 (fr) Procede de fabrication d'engrais phosphates et produits obtenus
IE873052L (en) Calcium phosphate scale inhibition
ZA962838B (en) Method for the manufacture of calcium hydrogenphosphate from calcium phosphate
PL310689A1 (en) Method of simultaneously obtaining calcium phosphates and extraction-type phosphoric acid
IL85443A0 (en) Process for making phosphoric acid free from titanium

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed